Company
Newron Pharmaceuticals SPA
Newron Pharmaceuticals SPA has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Evenamide 15 mg bid | Phase 3 | Treatment-resistant Schizophrenia |
Latest
No recent events.
Follow Newron Pharmaceuticals SPA on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.